First Header Logo Second Header Logo

Mercedes Porosnicu

Concepts (136)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
5
2018
117
1.410
Why?
Vesicular stomatitis Indiana virus
4
2015
44
0.840
Why?
Carcinoma, Squamous Cell
2
2018
142
0.690
Why?
Outpatients
1
2018
49
0.640
Why?
Cisplatin
1
2018
69
0.640
Why?
Interferon-beta
1
2015
23
0.530
Why?
Oncolytic Virotherapy
1
2015
19
0.520
Why?
Interferon-alpha
1
2015
69
0.520
Why?
Mucositis
1
2014
8
0.500
Why?
Oropharyngeal Neoplasms
1
2014
13
0.500
Why?
Alphapapillomavirus
1
2014
9
0.500
Why?
Smoking
2
2017
439
0.410
Why?
Antineoplastic Agents
5
2018
547
0.360
Why?
Leukemia
2
2001
37
0.240
Why?
Piperazines
2
2001
56
0.240
Why?
Pentosyltransferases
1
2003
1
0.240
Why?
Cytosine Deaminase
1
2003
1
0.240
Why?
Pyrimidines
2
2001
60
0.240
Why?
Retrospective Studies
5
2018
3123
0.220
Why?
Fusion Proteins, bcr-abl
1
2001
8
0.200
Why?
Oxides
1
2001
15
0.200
Why?
Arsenicals
1
2001
12
0.200
Why?
Protein-Serine-Threonine Kinases
1
2001
44
0.200
Why?
Cell Line, Tumor
2
2015
682
0.160
Why?
Adult
5
2018
8470
0.160
Why?
Humans
11
2018
29246
0.160
Why?
Aged
5
2018
9516
0.160
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2001
401
0.160
Why?
Disease-Free Survival
2
2015
281
0.150
Why?
Neoplastic Cells, Circulating
1
2017
23
0.150
Why?
DNA, Neoplasm
1
2017
58
0.150
Why?
Middle Aged
5
2018
10875
0.150
Why?
Neoplasm Invasiveness
1
2017
189
0.140
Why?
Survival Rate
1
2018
795
0.140
Why?
Bilirubin
1
2015
22
0.130
Why?
Neoplasms, Second Primary
1
2015
16
0.130
Why?
Hematologic Neoplasms
1
2015
28
0.130
Why?
Oncolytic Viruses
1
2015
10
0.130
Why?
Anthracyclines
1
2015
51
0.130
Why?
Neoplasms
2
2017
612
0.130
Why?
Apoptosis
3
2001
337
0.130
Why?
Mutation
1
2017
469
0.130
Why?
Recombinant Proteins
1
2015
249
0.130
Why?
Quinazolines
1
2014
31
0.120
Why?
Radiation Tolerance
1
2014
22
0.120
Why?
Prognosis
1
2018
1365
0.120
Why?
Radiotherapy
1
2014
74
0.120
Why?
Tumor Cells, Cultured
5
2014
159
0.120
Why?
Stroke Volume
1
2015
281
0.110
Why?
Aged, 80 and over
3
2017
3728
0.110
Why?
Follow-Up Studies
1
2018
2114
0.110
Why?
Neoplasm Recurrence, Local
1
2015
337
0.110
Why?
Combined Modality Therapy
1
2014
525
0.110
Why?
Neoplasms, Experimental
2
2003
27
0.110
Why?
Patient Compliance
1
2014
212
0.110
Why?
Male
4
2018
17877
0.110
Why?
Female
4
2018
18247
0.100
Why?
Young Adult
1
2018
2413
0.100
Why?
Genes, p53
2
2017
23
0.090
Why?
Genes, ras
2
2017
26
0.090
Why?
Treatment Outcome
1
2014
3109
0.070
Why?
Mice, Inbred BALB C
2
2003
160
0.070
Why?
Genetic Vectors
2
2003
118
0.070
Why?
Drug Synergism
2
2001
67
0.060
Why?
Benzamides
2
2001
54
0.060
Why?
Flucytosine
1
2003
1
0.060
Why?
Prodrugs
1
2003
13
0.060
Why?
Virus Replication
1
2003
53
0.060
Why?
Fluorouracil
1
2003
73
0.060
Why?
Escherichia coli
1
2003
83
0.060
Why?
Recombinant Fusion Proteins
1
2003
97
0.060
Why?
Mice
3
2003
2375
0.060
Why?
Animals
4
2017
7309
0.050
Why?
Genetic Engineering
1
2002
19
0.050
Why?
Macrophage-1 Antigen
1
2001
1
0.050
Why?
X-Linked Inhibitor of Apoptosis Protein
1
2001
2
0.050
Why?
bcl-X Protein
1
2001
6
0.050
Why?
Genes, myc
1
2001
5
0.050
Why?
Hemoglobins
1
2001
42
0.050
Why?
Proto-Oncogene Proteins c-bcl-2
1
2001
31
0.050
Why?
Proto-Oncogene Proteins c-akt
1
2001
69
0.050
Why?
Proto-Oncogene Proteins
1
2001
90
0.050
Why?
Membrane Glycoproteins
1
2001
97
0.050
Why?
Proteins
1
2001
140
0.050
Why?
Tumor Necrosis Factor-alpha
1
2001
200
0.040
Why?
Phosphorylation
2
2014
226
0.040
Why?
Computational Biology
1
2017
86
0.040
Why?
Lung Neoplasms
2
2017
384
0.040
Why?
Genes, erbB-1
1
2017
15
0.040
Why?
Clone Cells
1
2017
36
0.040
Why?
Genes, Neoplasm
1
2017
18
0.040
Why?
Sequence Analysis, DNA
1
2017
139
0.040
Why?
Oxidation-Reduction
1
2017
250
0.040
Why?
Protein Kinase Inhibitors
1
2017
77
0.040
Why?
Neoplastic Stem Cells
1
2017
90
0.040
Why?
Neoplasm Proteins
1
2017
141
0.030
Why?
Idarubicin
1
2015
7
0.030
Why?
Daunorubicin
1
2015
26
0.030
Why?
Gene Expression Profiling
1
2017
321
0.030
Why?
Radiotherapy Dosage
1
2015
98
0.030
Why?
Doxorubicin
1
2015
55
0.030
Why?
Antibiotics, Antineoplastic
1
2015
62
0.030
Why?
Disease Progression
1
2017
572
0.030
Why?
Ventricular Dysfunction, Left
1
2015
137
0.030
Why?
Radiation, Ionizing
1
2014
22
0.030
Why?
Oxidative Stress
1
2015
223
0.030
Why?
Phenotype
1
2014
630
0.030
Why?
Breast Neoplasms
1
2015
672
0.020
Why?
Thymidine Kinase
1
2002
5
0.010
Why?
DNA, Recombinant
1
2002
9
0.010
Why?
Interferons
1
2002
17
0.010
Why?
Mammary Neoplasms, Animal
1
2002
10
0.010
Why?
Interleukin-4
1
2002
21
0.010
Why?
Cricetinae
1
2002
59
0.010
Why?
Neoplasm Transplantation
1
2002
76
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2002
152
0.010
Why?
Base Sequence
1
2002
242
0.010
Why?
Mice, Inbred C3H
1
2001
23
0.010
Why?
3T3 Cells
1
2001
14
0.010
Why?
Eukaryotic Initiation Factor-2
1
2001
4
0.010
Why?
eIF-2 Kinase
1
2001
8
0.010
Why?
Cytochrome c Group
1
2001
1
0.010
Why?
Genes, abl
1
2001
1
0.010
Why?
Molecular Sequence Data
1
2002
354
0.010
Why?
Annexin A5
1
2001
8
0.010
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2001
10
0.010
Why?
Apoptosis Regulatory Proteins
1
2001
33
0.010
Why?
Ligands
1
2001
81
0.010
Why?
Drug Combinations
1
2001
86
0.010
Why?
Survival Analysis
1
2002
440
0.010
Why?
Melanoma
1
2002
148
0.010
Why?
Blotting, Western
1
2001
281
0.010
Why?
Cells, Cultured
1
2002
801
0.010
Why?
Glioblastoma
1
2001
143
0.010
Why?
Mice, Inbred C57BL
1
2002
712
0.010
Why?
Rats
1
2001
1605
0.010
Why?
Porosnicu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (136)
Explore
_
Co-Authors (22)
Explore
_
Similar People (51)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_